Searched for
OLIGONUCLEOTIDES
Aragen steps up investment in complex drug modalities; plans 500 KL new CDMO capacityAragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...- Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 targetJefferies has initiated coverage on Anthem Biosciences with a Buy rating and Rs 1,050 target, implying around 20% upside. The brokerage is ...
- In 2017, two parents asked scientist Stanley Crooke to create treatments for their children's rare mutations. Years later, a custom drug cut one boy's seizures by 90% and helped him walk on his own for the first timeMedicine is undergoing a profound transformation by shifting focus from populations to individual patients. A novel custom drug for rare ge...
- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...
- Cohance Lifesciences shares rocket 43% in just 2 trading sessions. Here’s what is fuelling the surgeCohance Lifesciences shares surged over 43% in two days following the appointment of former Cipla CEO Umang Vohra as Executive Chairman and...
- Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang VohraShares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and...
- Cohance Lifesciences announces $10 million investment in US-based armCohance Lifesciences is investing USD 10 million to expand bioconjugation capabilities at its US subsidiary, NJ Bio, enhancing its ADC solu...
- Suven Pharma shares in focus after Q3 profit jumps 78% YoY, revenue up 40%Suven Pharma reported a 78% YoY rise in Q3FY25 net profit to Rs 83.3 crore, with revenue growing 40% to Rs 307.2 crore, driven by its CDMO ...
- Suven Pharma Q3 Results: Net profit surges 78% to Rs 83 crore, revenue up 40%Suven Pharma, backed by Advent, reported a 78% year-on-year rise in net profit to Rs 83.3 crore for Q3FY25 driven by strong demand and busi...
- Anthem Biosciences files DRHP for Rs 3,395 crore IPOAnthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True Nort...
- Anthem Biosciences files DRHP for Rs 3,395 crore IPOAnthem Biosciences has filed its DRHP for an IPO. The issue comprises an offer for sale of up to Rs 3,395 crore by promoters and investors....
- Suven Pharma sets sights on M&As to scale up tech expertise & order bookSuven Pharmaceuticals, backed by Advent International, is eyeing further mergers and acquisitions to bolster its capabilities and order boo...
- Syngene International Q2 Results: Net profit drops 9% to Rs 106 croreSyngene International, the contract research and manufacturing services arm of Biocon reported a 9% year-on-year (YoY) drop in net profit t...
- Cipla expects to commence supplies to US from China plant later this yearCipla plans to start supplying from its China facility to the US market by the second half of the current fiscal year, following USFDA appr...
- Suven Pharma to acquire controlling stake in Hyderabad-based CDMO Sapala OrganicSuven will initially acquire a 67.5% equity stake of Sapala subject to customary working capital and net debt adjustments, the remaining st...
- Indian researchers developing treatment for rare genetic disorder 'Duchenne Muscular Dystrophy'The current therapeutic options available to treat DMD are minimal and highly expensive treatment with costs shooting up to Rs 2-3 crore pe...
- Alembic Pharma buys stake in US biotech RIGImmuneThe biotech was founded by Dr. Anna Pyle and Dr. Akiko Iwasaki is focused on the development of RNA based therapies for viral diseases and ...
- PIO led team's paper-based test can detect COVID-19 in less than five minutesThe researchers from the University of Illinois in the US created a graphene-based electrochemical biosensor with an electrical read-out se...
- Human antibodies produced in lab to treat diseasesLondon, July 24 (IANS) Scientists have developed a method to artificially produce specific human antibodies which can be used to treat a wi...
- Syngene Q2 net profit rises 31% to Rs 52 croreSyngene International, research arm of Biocon, today posted 30.69 per cent rise in its net profit at Rs 52.29 crore for the second quarter ...
Load More
